Activities

Activity Overview

Participants will learn what juvenile idiopathic arthritis (JIA) is, how to take a history and perform a physical exam, the process of diagnosing JIA, and the different types of JIA and what treatment options may be available.  Finally, participants will have access to resources to help them co-manage JIA patients and understand how to communicate with patient’s families about JIA.

Registration is complimentary.

Target Audience

Rheumatologists, primary care physicians, advanced practice nurses, nurses, physician assistants, residents, educators, fellows in training and rheumatology interprofessionals who care for pediatric patients with rheumatic diseases, particularly JIA.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Identify presenting symptoms and signs of juvenile idiopathic arthritis (JIA)

• Explain different JIA treatment options

• Describe possible complications of JIA

• Identify specialized needs for children with JIA

CE & MOC Information

• Credit must be claimed by December 17, 2026, at 11:59 PM ET.  

• By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. 

• After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

• All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity. 

Available Credit

• AMA PRA Category 1 Credit(s)™: 1.00

• ABIM MOC: 1.00 Medical Knowledge Points

Accreditation Statement

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797

See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet. 

AMA Designation Statement

The ACR designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Recognition Statement: American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of InternalMedicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure thatContinuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships within eligible companies including, but not limited to:

1. Advisor or review panel member

2. Consultant

3. Employee

4. Officer or Board Member

5. Grant/research support

6. Speaker/honoraria includes speaker’s bureau, symposia, and expert witness

7. Independent contractor

8. Executive role and/or ownership interest

9. Royalties and/or patent beneficiary

10. Intellectual property/patents

11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

12. Private investigator

13. Expert witness

14. Equity interest

15. Other: specify details 

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. Juvenile Idiopathic Arthritis (JIA) For Pediatric Providers Financial Relationship Disclosures.

Acknowledgement of Commercial Support

These educational materials were supported by a medical education grant from Pfizer Inc. to design and conduct an independent medical education program, RA-STEP. ​​Its contents are solely the responsibility of the authors and do not necessarily reflect the official views of Pfizer.​

Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.

Activity Overview

This activity allows primary care providers to increase their competence on the signs, symptoms, therapies, and management of rheumatoid arthritis, leading to increased early diagnosis of rheumatoid arthritis.

Registration is complimentary.

Target Audience

Primary care physicians, including internal medicine and family medicine practitioners, physician assistants, advanced practice nurses, and nurse practitioners.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Generate awareness and knowledge of rheumatoid arthritis (RA) in medically underserved areas

• Identify the signs and symptoms of RA

• Recognize how to initiate care and to make an appropriate referral.

CE & MOC Information

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797

See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet. 

Credit must be claimed by December 17, 2026, at 11:59 PM ET.  

All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity. 

Available Credit

• AMA PRA Category 1 Credit™: 1.00

• ABIM MOC: 1.00 Medical Knowledge Point

AMA Designation Statement

The American College of Rheumatology designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Recognition Statement: AmericanBoard of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance ofCertification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

1. Advisor or review panel member

2. Consultant

3. Employee

4. Officer or Board Member

5. Grant/research support

6. Speaker/honoraria includes speaker’s bureau, symposia, and expert witness

7. Independent contractor

8. Executive role and/or ownership interest

9. Royalties and/or patent beneficiary

10. Intellectual property/patents

11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan

12. Private investigator

13. Expert witness

14. Equity interest

15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

Editors and Planners

• Kelly Weselman, MD (Scientific Editor, Planner) – AbbVie11,BMS11, Gilead11, Johnson & Johnson11,Proctor and Gamble11

• Bruce Rothschild, MD (Associate Scientific Editor, Planner) – None

• Jennifer Barton, MD (Planner) – None

• Carole Dodge, CHT, OT (Planner) – None

• Maha Mohamad, MD (Planner) – None

• Linda A. Russell, MD (Planner) – None

• Charlie Gillihan, MD (Reviewer) – None

• Noelle Rolle, MD (Reviewer) – None

• Jeffrey Tharp, MD (Reviewer) – None

Acknowledgement of Commercial Support

Unrestricted medical educational grant support for this activity has been provided by: Pfizer.

Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.